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Infectious complications are a major cause of morbidity and mortality in patients
with chronic lymphocytic leukemia (CLL) due to impaired immunity secondary to
the disease itself and to the immunosuppressive therapies administered to these
patients. We report a 78-year-old woman with CLL who was treated with steroids
for autoimmune hemolytic anemia (AIHA). A few weeks later, she was admitted for
severe acute hepatitis with disseminated intravascular coagulation (DIC). Despite
the symptomatic treatment of DIC, standard reanimation and probabilistic
antibiotics, the patient died within 24h with severe hepatic failure. Autopsy was in
favor of a disseminated viral infection with esophageal, hepatic and pulmonary
cytopathologic lesions with acidophilic intranuclear inclusions suggestive of herpes
virus, even though HSV 1 and 2, CMV and HHV6 PCRs were negative. This case of
severe viral hepatitis with esophagitis occurring three weeks after the introduction
of high-dose steroid treatment for AIHA in a CLL patient calls for anti-herpetic
prophylaxis in such patients, immunodepressed by their diseases and the treatment
they receive.
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